Ireland.Circulation.2008;117(1):79–84.
271.RedfieldMM,JacobsenSJ,BurnettJCJr,etal.
Burdenofsystolicanddiastolicventricular
dysfunctioninthecommunity:appreciatingthe
scopeoftheheartfailureepidemic.JAMA.
2003;289(2):194–202.
272.AlvarezJA,OravEJ,WilkinsonJD,etal.
Competingrisksfordeathandcardiac
transplantationinchildrenwithdilated
cardiomyopathy:resultsfromthepediatric
cardiomyopathyregistry.Circulation.
2011;124(7):814–823.
273.AlexanderPM,DaubeneyPE,NugentAW,etal.
Long-termoutcomesofdilatedcardiomyopathy
diagnosedduringchildhood:resultsfroma
nationalpopulation-basedstudyofchildhood
cardiomyopathy.Circulation.
2013;128(18):2039–2046.
274.TsirkaAE,TrinkausK,ChenSC,etal.Improved
outcomesofpediatricdilatedcardiomyopathy
withutilizationofhearttransplantation.JAm
CollCardiol.2004;44(2):391–397.
275.KantorPF,AbrahamJR,DipchandAI,Benson
LN,RedingtonAN.Theimpactofchanging
medicaltherapyontransplantation-freesurvival
inpediatricdilatedcardiomyopathy.JAmColl
Cardiol.2010;55(13):1377–1384.
276.RusconiP,WilkinsonJD,SleeperLA,etal.
Differencesinpresentationandoutcomes
betweenchildrenwithfamilialdilated
cardiomyopathyandchildrenwithidiopathic
dilatedcardiomyopathy:Areportfromthe
pediatriccardiomyopathyregistrystudygroup.
CircHeartFail.2017;10(2).
277.FoersterSR,CanterCE,CinarA,etal.
Ventricularremodelingandsurvivalaremore
favorableformyocarditisthanforidiopathic
dilatedcardiomyopathyinchildhood:an
outcomesstudyfromthepediatric
cardiomyopathyregistry.CircHeartFail.
2010;3(6):689–697.
278.denBoerSL,LennievanOsch-GeversM,van
IngenG,etal.Managementofchildrenwith
dilatedcardiomyopathyinTheNetherlands:
implicationsofalowearlytransplantationrate.J
HeartLungTransplant.2015;34(7):963–969.
279.MichelsVV,MollPP,MillerFA,etal.The
frequencyoffamilialdilatedcardiomyopathyin
aseriesofpatientswithidiopathicdilated
cardiomyopathy.NEnglJMed.
1992;326(2):77–82.
280.KindelSJ,MillerEM,GuptaR,etal.Pediatric
cardiomyopathy:importanceofgeneticand
metabolicevaluation.JCardFail.
2012;18(5):396–403.
281.OuelletteAC,MathewJ,ManickarajAK,etal.
Clinicalgenetictestinginpediatric
cardiomyopathy:isbiggerbetter?ClinGenet.
2017.
282.HaasJ,FreseKS,PeilB,etal.Atlasofthe
clinicalgeneticsofhumandilated
cardiomyopathy.EurHeartJ.
2015;36(18):1123–1135a.
283.AkinrinadeO,OllilaL,VattulainenS,etal.
Geneticsandgenotype-phenotypecorrelationsin
finnishpatientswithdilatedcardiomyopathy.
EurHeartJ.2015;36(34):2327–2337.
284.HermanDS,LamL,TaylorMR,etal.
Truncationsoftitincausingdilated
cardiomyopathy.NEnglJMed.
2012;366(7):619–628.
285.PughTJ,KellyMA,GowrisankarS,etal.The
landscapeofgeneticvariationindilated
cardiomyopathyassurveyedbyclinicalDNA
sequencing.GenetMed.2014;16(8):601–608.
286.KamdarF,GarryDJ.Dystrophin-deficient
cardiomyopathy.JAmCollCardiol.
2016;67(21):2533–2546.
287.HoogerwaardEM,BakkerE,IppelPF,etal.
Signsandsymptomsofduchennemuscular
dystrophyandbeckermusculardystrophy